Julian Adams, Ph.D.

Julian Adams, Ph.D.

Chair of the BoardatElicio Therapeutics· In proxies 2023–2025

Julian Adams, Ph.D. sits on 5 public boards.

Boards1

  • Elicio TherapeuticsChair · 2 yr on the boardIndependentNominating and Corporate Governance—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. Elicio TherapeuticsPublic company · 3 yr
    • Chair of the Board2023 – Present · 3 yrStock in role -78%
  2. ImmunyxPublic company
    • Director? – PresentNo stock prices for these years
  3. Neon Therapeutics, Inc.Public company
    • Director? – PresentNo stock prices for these years
  4. BioNTech SEPublic company · 1 yr
    • Director2017 – 2018 · 1 yrNo stock prices for these years
  5. Pieris Pharmaceuticals, Inc.Public company · 2 yr
    • Director2016 – 2018 · 2 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?